2022 Fall Conference | LU2 - Overcoming Barriers in Management and Leadership

Date Friday 10/28/22

Time 10:00 AM - 11:30 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) James C. Stevens, MD, FAAN

Topic(s) Leadership

Learning Objectives Participants should become familiar with the concepts of management and leadership and what it takes to successfully navigate and influence in the health care landscape today. Neurology leaders will share personal stories, real life examples, and relevant anecdotes that demonstrate that developing as a manager and leader is a lifelong journey and that leadership can occur both formally and informally. Panelists will highlight shifts they have experienced and opportunities and challenges they see on the horizon of neurology and healthcare. This program will not be available within the virtual platform.

CME Available 1.50 CME credits

Core Competencies Professionalism

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator

Teaching Styles Didactic

Program Materials

Event Timeline
10:00 AM - 10:05 AM PDT	Introduction	Welcome James C. Stevens, MD, FAAN
10:05 AM - 10:20 AM PDT	Speaker	Observations on Management and Leadership James C. Stevens, MD, FAAN
10:20 AM - 11:00 AM PDT	Speaker	Panel Discussion David A. Evans, MBA, Hope M. O'Brien, MD, MBA, FAAN, James C. Stevens, MD, FAAN, Brad C. Klein, MD, MBA, FAAN, Robin Stubblefield, MA, ACC
11:00 AM - 11:30 AM PDT	Q&A	Questions and Answers David A. Evans, MBA, Hope M. O'Brien, MD, MBA, FAAN, James C. Stevens, MD, FAAN, Brad C. Klein, MD, MBA, FAAN, Robin Stubblefield, MA, ACC

Faculty Disclosures
James C. Stevens, MD, FAAN	Dr. Stevens has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Physicians Health Plan.
Hope M. O'Brien, MD, MBA, FAAN	The institution of Dr. O'Brien has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. An immediate family member of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zenica. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. O'Brien has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Scilex. The institution of Dr. O'Brien has received research support from Abbvie. The institution of Dr. O'Brien has received research support from Eli Lilly. Dr. O'Brien has received publishing royalties from a publication relating to health care. Dr. O'Brien has a non-compensated relationship as a Accreditation Council Member with UCNS that is relevant to AAN interests or activities.
David A. Evans, MBA	Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon Therapeutics/Amgen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Averitas . Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Mr. Evans has stock in NeuroNet GPO. Mr. Evans has stock in NeuroNet Pro. Mr. Evans has stock in NeuroDiscovery.AI.
Brad C. Klein, MD, MBA, FAAN	Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Scilex. The institution of Dr. Klein has received research support from AbbVie. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with AppsbyDocs, LLC. Dr. Klein has a non-compensated relationship as a Chair, Practice Management Committee with American Headache Society that is relevant to AAN interests or activities.
Robin Stubblefield, MA, ACC	Robin Stubblefield, MA, ACC has nothing to disclose.

��ɫ��

��ɫ��